Skip to main content

Table 1 Main general and functional data of the overall population of COPD patients

From: Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients

COPD patients

n

\( \overline{\mathrm{X}} \)±SD

Age (years)

66

70 ± 8

Sex (male %)

66

52(82)

Tobacco (pack-year)

66

41 ± 11

Anthropometry

 Weight (kg)

66

71 ± 18

 BMI (kg/m2)

66

26.2 ± 6.5

 FFMI (kg/m2)

52

16.9 ± 2.7

 Exacerbations (n)

66

1.3 ± 1.2

Blood test and flow cytometry

 Eosinophils (total/mm3)

66

199 ± 164

 HCMV+ (%)

35

31(89)

 NK

59

19.1 ± 10

 NKG2C+

63

14.4 ± 17

 NKG2A+

46

29.2 ± 17

Functional testing

 FEV1 (% pred.) pre/post bd

66

37 ± 14/39 ± 15

 FEV1/FVC (%) pre/post bd

66

44 ± 11/44 ± 12

 RV/TLC (%)

60

63 ± 11

 DLco (% pred.)

60

44 ± 20

 Kco (% pred.)

60

51 ± 20

 SpO2 (%)

66

93 ± 3

 6MWT (m)

56

359 ± 122

CT Scan

 Emphysema (%)

58

44(76)

 Bronchiectasis (%)

58

13(22)

  1. Data are presented as means ± standard deviation (\( \overline{\mathrm{X}} \) ±SD) or n(percentages). Abbreviations: BMI body mass index; FFMI fat free mass index; FEV1 forced expiratory volume in the first second; bd bronchodilator; FVC forced vital capacity; RV residual volume; TLC total lung capacity; DLco carbon monoxide transfer coefficient; Kco Krogh index (DLco/alveolar volume; SpO2 oxygen saturation (pulse oximetry); 6MWT six-minute walking test distance. CT computed tomography,